Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Clicks: 297
ID: 273232
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.5
/100
25 views
25 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (7 words).
Try re-searching for a better abstract.
| Reference Key |
s2020thehydroxychloroquine
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Rathi S;Ish P;Kalantri A;Kalantri S;; |
| Journal | The Lancet. Infectious Diseases |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
india
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
covid-19
sars-cov-2
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Family Characteristics
pneumonia
betacoronavirus
coronavirus infections / drug therapy
coronavirus infections / prevention & control*
pandemics / prevention & control*
viral / prevention & control*
chloroquine / therapeutic use
pmid:32311324
pmc7164849
doi:10.1016/s1473-3099(20)30313-3
sahaj rathi
pranav ish
shriprakash kalantri
chloroquine / supply & distribution
contact tracing
hydroxychloroquine / supply & distribution
hydroxychloroquine / therapeutic use*
pre-exposure prophylaxis*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.